Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICD reimbursement

This article was originally published in The Gray Sheet

Executive Summary

Principal investigators in the Guidant-sponsored MADIT IItrial meet with Medicare officials Sept. 20 to discuss request for national coverage of prophylactic implantation of ICDs in patients with a prior heart attack and an ejection fraction of less than 30% without requiring evidence of arrhythmias. Guidant anticipates the imminent release of physician guidelines endorsing prophylactic ICD implantation...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017186

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel